The Nifedipine Capsules, cataloged under National Stock Number 6505-01-242-0950, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 4 specifications, cited from the U.S. Government catalog. 6 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 2 items share a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-242-0950 |
| Item Name | Nifedipine Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 100.000 |
| Active Medicament Medicinal Strength | 20.000 MILLIGRAMS NIFEDIPINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Reference | Meaning |
|---|---|
| PROCARDIA CAPSULES | 5/1 Secondary reference U.S. Government activity |
| PROCARDIA | 5/1 Secondary reference U.S. Government activity |
| NDC00228-2530-10 | 5/9 Secondary reference Actavis Elizabeth Llc Dba Actavis Us Div Actavis Pharma, Inc. |
| NDC00069-2610-66 | 3/2 Design control — primary reference U.S. Government activity |
| NDC00026-8821-51 | 5/9 Secondary reference Bayer Pharmaceuticals Corporation |
| NDC00904-0408-61 | 5/1 Secondary reference Major Pharmaceuticals Inc |
NSN 6505-01-242-0950 is a Nifedipine Capsules, classified under FSC 6505, Drugs and Biologicals. Status: active.
2 possible matches (shared part number, not a government interchangeability claim): 6505-01-242-0951, 6505-01-243-4525. Verify interchangeability with system specifications before substitution.
Key specifications for 6505-01-242-0950: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 100.000; Part Name Assigned by Controlling Agency: NIFEDIPINE CAPSULES USP 20MG 100S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.